Pursuant to clause 96 of the COVID-19 Public Health Response (Protection Framework) Order 2021 (“Order”), I, the Director-General of Health, hereby specify the following examination or tests for COVID-19 to be an applicable COVID-19 test for the purposes of clause 96 of the Order:

1. For persons travelling in accordance with clauses 96, 97 and 98 of the Order, testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral ribonucleic acid:
   1. using reverse transcription polymerase chain reaction (RT-PCR) or transcription-mediated amplification (TMA);
   2. on a sample collected by taking nasopharyngeal swabs, oropharyngeal and anterior nasal swabs, or saliva;
   3. which is undertaken in accordance with a laboratory’s accreditation to ISO15189;
2. Or a Point-of-care test that has been;
   1. approved for use under clause 8 of the COVID-19 Public Health Response (Point-of-care Tests) Order 2021; and
   2. supervised by a medical practitioner.

Dated this 15th day of December 2021.

Dr ASHLEY BLOOMFIELD, Director-General of Health.